| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biohybrid artificial pancreas based on macrocapsule device
|
Hou, Q.P
|
|
1999
|
35 |
2-3 |
p. 271-287
17 p.
|
artikel
|
| 2 |
Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment 1 Abbreviations: AIA, antiinsulin antibody; CAPD, continuous ambulatory dialysis; CSII, continuous subcutaneous insulin infusion; DCCT, diabetes control complications trial; FIR, far infrared radiation; GLP1, glucagon-like peptide 1; GH, growth hormone; HbA1c, glycated hemoglobin; IDDM, insulin-dependent diabetes mellitus; IGF1, insulin-like growth factor 1; i.p., intraperitoneal; ISF, interstitial fluid; ISGIID, International Study Group on Implantable Insulin Delivery Devices; i.v., intravenous; MDI, multiple daily injections; NIDDM, non-insulin-dependent diabetes mellitus; PAI1, plasminogen activator inhibitor 1; rh IGF1, recombinant human insulin-like growth factor 1; SHBG, sex hormone binding globulin; SC, subcutaneous; SMBG, self monitoring of blood glucose; TG, triglycerides. 1
|
Jeandidier, Nathalie
|
|
1999
|
35 |
2-3 |
p. 179-198
20 p.
|
artikel
|
| 3 |
Editorial
|
|
|
1999
|
35 |
2-3 |
p. 141-142
2 p.
|
artikel
|
| 4 |
Inhaled insulin 1 Abbreviations: DM, diabetes mellitus; AIDs, acquired immune deficiency syndrome; SC, subcutaneous; DCCT, Diabetes Control and Complications Trial; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; i.v., intravenous; DDPC, di-decanoyl-alpha-phosphatidylcholine; AUC, area under the curve; INH, inhaled; C max, maximum serum concentration; C min, minimum serum concentration; T max, time of maximum serum concentration; NS, not significant; HbA1c, hemoglobin A1c; OA, oral agent; SD, standard deviation; MDI, metered dose inhaler; DPI, dry powder inhaler; MMAD, mass median aerodynamic diameter; CMC, critical micelle concentration; SR, sustained release; PLGA, poly lactic acid-co-glycolic acid; GI, gastrointestinal, GSD, geometric standard deviation; TLC, total lung capacity; VC, vital capacity; SMK, smokers; MW, molecular weight; MP, melting point. 1
|
Patton, John S.
|
|
1999
|
35 |
2-3 |
p. 235-247
13 p.
|
artikel
|
| 5 |
Insulin analogs with improved pharmacokinetic profiles
|
Brange, Jens
|
|
1999
|
35 |
2-3 |
p. 307-335
29 p.
|
artikel
|
| 6 |
Intranasal insulin delivery and therapy 1 Abbreviations: α-CD, α-cyclodextrin; β-CD, β-cyclodextrin; γ-CD, γ-cyclodextrin; AUC, area under the plasma/serum concentration versus time curve; C max, maximum or peak plasma/serum concentration; C min, minimum plasma/serum concentration; DDPC, didecanoyl-L-α-phosphatidylcholine; DM-β-CD, dimethyl-β-cyclodextrin; EDTA, ethylenediaminetetraacetic acid; FITC, fluorescein isothiocyanate; HLB, hydrophile–lipophile balance; hGH, human growth hormone; HP-β-CD, hydroxy-propyl-β-cyclodextrin; HPC, hydroxypropylcellulose; HSA, human serum albumin; Hyaff 11, hyaluronic acid ester; IDDM, insulin-dependent diabetes mellitus; Ig, immunoglobulin; Laureth-9, polyoxyethylene-9-lauryl ether; LPC, lysophosphatidylcholine; LPG, lysophosphatidylglycerol; MCC, microcrystalline cellulose; MTR, mucociliary transport rate; NIDDM, non-insulin-dependent diabetes mellitus; PC, phosphatidylcholine; RAMEB, randomly methylated β-cyclodextrin; SDC, sodium deoxycholate; SGC, sodium glycocholate; STDHF, sodium taurodihydrofusidate; 99mTc, 99mtechnetium; TER, transepithelial resistance. 1
|
Hinchcliffe, Michael
|
|
1999
|
35 |
2-3 |
p. 199-234
36 p.
|
artikel
|
| 7 |
Oral insulin delivery 1 Abbreviations: GI, gastrointestinal; IDDM, insulin-dependent diabetes mellitus; IU, international units; NIDDM, non-insulin-dependent diabetes mellitus; PIN, phase inversion nanoencapsulation; ZOT, zona occludens toxin. 1
|
Carino, Gerardo P
|
|
1999
|
35 |
2-3 |
p. 249-257
9 p.
|
artikel
|
| 8 |
Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM) – genetic predisposition and metabolic abnormalities
|
Jun, Hee-Sook
|
|
1999
|
35 |
2-3 |
p. 157-177
21 p.
|
artikel
|
| 9 |
Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus 1 Abbreviations: s.c., subcutaneous; i.p., intraperitoneal; i.v., intravenous; IFA, incomplete Freund's adjuvant; DTP, diphtheria-tetanus-pertussis; LCMV, lymphocytic choriomeningitis virus; GAD, glutamic acid decarboxylase; ICA, islet cell autoantibody; JDF, juvenile diabetes foundation; IAA, insulin autoantibody; GAA, glutamic acid decarboxylase autoantibody; DM, diabetes mellitus; RIA, radioimmunoassay; AA, autoantibody; kD, kilodalton; FPIR, first phase insulin release; IIF, indirect immunofluoresence; IGT, impaired glucose tolerance; OGT, oral glucose tolerance. 1
|
Graves, Patricia M.
|
|
1999
|
35 |
2-3 |
p. 143-156
14 p.
|
artikel
|
| 10 |
Site-specific insulin conjugates with enhanced stability and extended action profile
|
Uchio, Takashi
|
|
1999
|
35 |
2-3 |
p. 289-306
18 p.
|
artikel
|
| 11 |
Treatment of type I diabetes using encapsulated islets 1 Abbreviations: Tx, transplantation; IEQ, islet equivalent; BUN, blood urea nitrogen. 1
|
Soon-Shiong, Patrick
|
|
1999
|
35 |
2-3 |
p. 259-270
12 p.
|
artikel
|
|
Tijdschrift beschrijving